Trial Profile
An Open, Multi-centre Trial Comparing the Efficacy and Safety of Two Different Treatment Regimens of Topical MOB015 Treatment of Distal Subungual Onychomycosis (DSO)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Mar 2015
Price :
$35
*
At a glance
- Drugs Terbinafine (Primary)
- Indications Onychomycosis
- Focus Therapeutic Use
- Sponsors Moberg Pharma
- 13 Mar 2015 Data from this study presented at the 73rd Annual Meeting of the American Academy of Dermatology (AAD) according to a Moberg Pharma media release.
- 28 Apr 2014 New trial record